Filing #7337586

Available Statements

K Pharma,Inc. - filed on May 14, 2024

Comprehensive Income Attributable To

Taxonomy: jppfs-2013

Comprehensive Income Attributable To

Taxonomy: jppfs-2013

Comprehensive Income Attributable To

Taxonomy: jppfs-2020

Comprehensive Income Attributable To

Taxonomy: jppfs-2023

Other Comprehensive Income

Taxonomy: jppfs-2023

Year To Quarter End Consolidated Statement Of Comprehensive Income

Taxonomy: jppfs-2013

Members' Equity

Taxonomy: jppfs-2016

Notes - Consolidated Statement Of Changes In Equity

Taxonomy: jpcrp-2020

Notes - Equity

Taxonomy: jpcrp-2015

Notes - Equity

Taxonomy: jpcrp-2017

Notes - Semi-Annual Consolidated Statement Of Changes In Equity

Taxonomy: jpcrp-2020

Notes - Semi-Annual Statement Of Changes In Equity

Taxonomy: jpcrp-2013

Notes - Statement Of Changes In Equity

Taxonomy: jpcrp-2015

Shareholders' Equity

Taxonomy: jppfs-2013

Cash Flows From Operating Activities

Taxonomy: jppfs-2013

Statement Of Cash Flows

Taxonomy: jppfs-2013

Statement Of Cash Flows

Taxonomy: jppfs-2013

Assets For Lease

Taxonomy: jpcrp-2021

Buildings

Taxonomy: jppfs-2020

Business Policy, Business Environment, Issues To Address, Etc.

Taxonomy: jpcrp-2019

Business Results Of Group

Taxonomy: jpcrp-2019

Capital Surplus

Taxonomy: jppfs-2013

Company Name, Title And Name Of Representative, And Address Of Registered Head Office

Taxonomy: jpcrp-2021

Consolidated Or Non-Consolidated

Taxonomy: jppfs-2013

Consolidated Or Non-Consolidated

Taxonomy: jppfs-2013

Consolidated Or Non-Consolidated

Taxonomy: jppfs-2015

Consolidated Or Non-Consolidated

Taxonomy: jppfs-2018

Cover Page

Taxonomy: jpcrp-2021

Description Of Reportable Segments

Taxonomy: jpcrp-2020

Description Of Reportable Segments

Taxonomy: jpcrp-2021

Disclosure Of Corporate Information Form No. 4-3 Quarterly Securities Report

Taxonomy: jpcrp-2022

Education And Research And Incidental Operating Revenue

Taxonomy: jppfs-2020

Employees

Taxonomy: jpcrp-2023

Financial Information

Taxonomy: jpcrp-2019

Increase In Surplus Or Decrease In Deficit

Taxonomy: jppfs-2016

Issued Shares

Taxonomy: jpcrp-2020

Key Financial Data Of Reporting Company

Taxonomy: jpcrp-2023

Leased Assets

Taxonomy: jppfs-2021

Liabilities

Taxonomy: jppfs-2015

Long-Term Loans Receivable

Taxonomy: jppfs-2020

Major Shareholders After Third Party Allotment

Taxonomy: jpcrp-2022

Metrics And Targets

Taxonomy: jpcrp-2023

Net Assets

Taxonomy: jppfs-2013

Non-Operating Expenses

Taxonomy: jppfs-2022

Non-Operating Income

Taxonomy: jppfs-2021

Notes - Segment Information, Etc.

Taxonomy: jpcrp-2017

Notes - Segment Information, Etc.

Taxonomy: jpcrp-2019

Notes - Segment Information, Etc.

Taxonomy: jpcrp-2020

Notes - Significant Accounting Policies

Taxonomy: jpcrp-2020

Operating Miscellaneous Expenses

Taxonomy: jppfs-2013

Particulars Of Book Building

Taxonomy: jpcrp-2023

Property, Plant And Equipment

Taxonomy: jppfs-2022

Quarterly Consolidated Balance Sheet

Taxonomy: jppfs-2013

Remuneration For Directors (And Other Officers)

Taxonomy: jpcrp-2020

Segment Information

Taxonomy: jpcrp-2019

Semi-Annual Consolidated Statement Of Income

Taxonomy: jppfs-2023

Share Acquisition Rights

Taxonomy: jpcrp-2021

Statement Of Changes In Net Assets

Taxonomy: jppfs-2013

Statement Of Income

Taxonomy: jppfs-2013

Terms Of Public Offering

Taxonomy: jpcrp-2021

Total Number Of Issued Shares / Number Of Voting Rights Held By All Shareholders

Taxonomy: jpcrp-2020

Underwriting Of Bonds

Taxonomy: jpcrp-2023

Valuation And Translation Adjustments

Taxonomy: jppfs-2013

Year To Quarter End Statement Of Income

Taxonomy: jppfs-2013

Talk to a Data Expert

Have a question? We'll get back to you promptly.